Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cybin Inc. Common Shares
(NY:
CYBN
)
6.170
+0.280 (+4.75%)
Official Closing Price
Updated: 8:00 PM EST, Nov 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc. Common Shares
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
41
42
Next >
Cybin to Host Virtual R&D Day on February 28, 2023
January 26, 2023
From
Cybin Inc.
Via
Business Wire
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
↗
January 25, 2023
Via
Benzinga
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
↗
January 25, 2023
Legalizing Psychedelics From New York To Washington And Five In Between: Which State Will Go First?
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
↗
January 24, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2023
↗
January 17, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 11, 2023
↗
January 11, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 10, 2023
↗
January 10, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 23, 2023
↗
January 23, 2023
Via
Benzinga
Largest Psychedelic Stocks +3% This Week; Now +15% YTD
↗
January 21, 2023
Our Psychedelic Drug Stocks Index tracks the six largest psychedelic stocks, by market capitalization, that research the treatment of mental illnesses based on the use of one or more of 10 different...
Via
Talk Markets
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
January 20, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023
↗
January 19, 2023
Via
Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
January 18, 2023
Via
Benzinga
Cybin Touts Promising Results From Sponsored Kernel Flow Study Measuring Psychedelic Effects On The Brain
↗
January 18, 2023
Cybin Inc.
Via
Benzinga
ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today
↗
January 06, 2023
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Promising Results from Kernel Flow(R) Feasibility Study
January 18, 2023
Via
Investor Brand Network
Cybin Announces Promising Results from Sponsored Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain
January 18, 2023
From
Cybin Inc.
Via
Business Wire
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More
↗
January 17, 2023
Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January.
Via
Benzinga
Psychedelics Companies Join The Race To Develop Much-Needed Anxiety Treatment
↗
January 16, 2023
Life sciences biotech company Cybin Inc. (NYSE: CYBN) announced its selection of the Generalized Anxiety Disorder (GAD) with or without Major Depressive Disorder (MDD) as the target indication for its...
Via
Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
↗
January 16, 2023
Via
Benzinga
A "Multi-Bagger" Portfolio For 2023 - Introduction
↗
January 14, 2023
I am optimistic that the market will perform better in 2023 so I've put together a basket of 10 stocks that could well realize multi-bagger returns this year.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From January 13, 2023
↗
January 13, 2023
Via
Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
↗
January 12, 2023
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Selects Generalized Anxiety Disorder as Target Indication for CYB004
January 12, 2023
Via
Investor Brand Network
Cybin Selects Generalized Anxiety Disorder as Target Indication for Deuterated DMT Molecule CYB004
January 12, 2023
From
Cybin Inc.
Via
Business Wire
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
January 11, 2023
Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine...
Via
Benzinga
Why Lightning eMotors Shares Are Trading Lower By 9%; Here Are 20 Stocks Moving Premarket
↗
January 11, 2023
Gainers Broadwind, Inc. (NASDAQ: BWEN) rose 68.1% to $3.80 in pre-market trading after the company reported transformational two-year, $175 million wind tower order with global wind turbine...
Via
Benzinga
Where Are Psychedelics Headed In 2023? These Two Heavy Hitters Share Their Plans
↗
January 09, 2023
It’s the beginning of 2023 and psychedelics companies are updating the public on their developmental and clinical progress as well as their selected milestones for the year.
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 9, 2023
↗
January 09, 2023
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Status Update on Clinical Development Programs
January 09, 2023
Via
Investor Brand Network
Cybin Outlines Upcoming Priorities and Milestones for its Clinical Development Programs
January 08, 2023
From
Cybin Inc.
Via
Business Wire
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
41
42
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today